POLR3G and cancer: Notably, patient-matched breast, thyroid, and prostate primary cancer tissues are characterized by less, or insignificantly higher POLR3G bias, suggesting POLR3G dysregulation may be less common in these and potentially other contexts (Supplementary Fig. 4a–c).